Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,051 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).
Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Kunadian V, Leonardi S, Mehran R, Montalescot G, Niebauer J, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M. Navarese EP, et al. Among authors: oliva a. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):271-290. doi: 10.1093/ehjcvp/pvad016. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36869784 Free article.
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.
Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA. Valgimigli M, et al. Among authors: oliva a. Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):462-496. doi: 10.1093/ehjcvp/pvad032. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37120728 Free article.
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
Baber U, Jang Y, Oliva A, Cao D, Vogel B, Dangas G, Sartori S, Spirito A, Smith KF, Branca M, Collier T, Pocock S, Valgimigli M, Kim BK, Hong MK, Mehran R. Baber U, et al. Among authors: oliva a. Circulation. 2024 Feb 20;149(8):574-584. doi: 10.1161/CIRCULATIONAHA.123.067283. Epub 2023 Oct 23. Circulation. 2024. PMID: 37870970 Free article.
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines.
Landi A, Aboyans V, Angiolillo DJ, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M. Landi A, et al. Among authors: oliva a. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):173-180. doi: 10.1093/ehjacc/zuad158. Eur Heart J Acute Cardiovasc Care. 2024. PMID: 38170562
Biochemical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population.
Gitto M, Kotinas AS, Terzi R, Oliva A, Zagoreo J, Reimers B, Stefanini GG, Mirani M, Favacchio G, Condorelli G, Panico C. Gitto M, et al. Among authors: oliva a. J Cardiovasc Pharmacol. 2022 Jul 1;80(1):140-147. doi: 10.1097/FJC.0000000000001280. J Cardiovasc Pharmacol. 2022. PMID: 35436244 Free PMC article.
1,051 results